Puma Biotechnology, Inc. (PBYI)
5.52
+0.12
(+2.22%)
USD |
NASDAQ |
Dec 09, 16:00
5.55
+0.03
(+0.54%)
After-Hours: 20:00
Puma Biotechnology Shareholders Equity (Quarterly): 115.27M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Nephros, Inc. | 10.01M |
| Sensus Healthcare, Inc. | 51.19M |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Vanda Pharmaceuticals, Inc. | 466.00M |
| Vertex Pharmaceuticals, Inc. | 17.32B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 202.86M |
| Total Liabilities (Quarterly) | 87.59M |
| Debt to Equity Ratio | 0.3561 |
| Current Ratio | 1.736 |
| Net Debt Paydown Yield | 4.30% |